Search
Making More Health at a Glance.pdf
Partnering in Retinal Health MAY 2024 CORP.pdf
Partnering in Mental Health Disorders MAY 2024 CORP _0.pdf
Making More Health - CREATE - Magazine Social Entrepreneurship - Edition 2023
Partnering Interests in Retinal Health
partnering-retinal-health-may-2023-corp.pdf
Partnering in Oral Health MAY 2024 CORP_0.pdf
BI-access-to-healthcare-strategy
public health
Cat Health Booklet.pdf
ForBetterHealth.pdf
Announcement for Imagine - our new sustainability story hub
Discover Imagine, our sustainability story hub, showcasing how we drive health equity and advance sustainable healthcare solutions for a better future
Knowing the enemy: PRRS and PCVD
The swine industry is constantly vigilant of viruses such as PRRS and PCV2 (PCVD). Learn about prevention, symptoms knowledge, and control measures to make a difference.
discontinuation-bi-1467335-diabetic-retinopathy
The discontinuation of the development of BI 1467335 in diabetic retinopathy has been announced
Phospholipid modulator
Phospholipid modulator
Vascular modulator
Vascular modulator
Breakthrough Designation granted in US and China
SPEVIGO® granted Breakthrough Therapy Designation in the U.S. for the prevention of generalized pustular psoriasis flares
The Goals to Improve Living with GPP
An article that describes the current goals to improve the lives of those living with generalized pustular psoriasis
More Green Overview
Our pillar MORE GREEN encompasses environmental initiatives that consider many different aspects.
Making sustainable medicines through eco-design
Our goal is to minimize the environmental footprint of our medicines through integration of eco-design and green chemistry across the entire lifecycle
The Research Process
The Research Process
Parasiticides
Parasiticides
CHMP_opinion_nintedanib_ILD_PF
Nintedanib received a CHMP positive opinion for the treatment of patients with other chronic fibrosing ILDs with a progressive phenotype beyond IPF
Horses
Horses